1.             Introduction

1.1       Study Scope

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        US Irritable Bowel Syndrome Treatment Market – ByType

1.3.2        US Irritable Bowel Syndrome Treatment Market – By Product

1.3.3        US Irritable Bowel Syndrome Treatment Market – By Distribution Channel

2.             Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             US Irritable Bowel Syndrome Treatment Market Landscape

4.1       Market Overview

4.2       PEST Analysis

4.2.1        US: PEST Analysis

4.3       Expert Opinion

5.             US Irritable Bowel Syndrome Treatment Market –  Key Market Dynamics

5.1       Key Drivers

5.1.1        Increasing prevalence of irritable bowel syndrome and associated conditions

5.1.2        Increasing number of FDA approvals and drug developments

5.2       Key Market Restraints

5.2.1        Limited number of product availability and treatment inefficiency

5.2.2        Disruptive effect of corona virus on the US economy

5.3       Key Market Opportunities

5.3.1        Increasing disposable incomes of the population

5.4       Future Trends

5.4.1        Development of medical devices for the treatment of irritable bowel syndrome

5.5       Impact Analysis

6.             Irritable Bowel Syndrome Treatment – US Market Analysis

6.1       US Irritable Bowel Syndrome Treatment Market Overview

6.2       Market Positioning of Key Players

7.             US Irritable Bowel Syndrome Treatment Market Analysis – By Type

7.1       Overview

7.2       Global Irritable Bowel Syndrome Treatment Market Share by Type 2019 & 2027 (%)

7.3       Mixed IBS (IBS-M)

7.3.1        Overview

7.3.2        Mixed IBS (IBS-M) Market Revenue and Forecast to 2027 (US$ Mn)

7.4       IBS with Diarrhea (IBS-D)

7.4.1.1      IBS with Diarrhea Market Revenue and Forecast to 2027 (US$ Mn)

7.5       IBS with Constipation (IBS-C)

7.5.1.1      IBS with Constipation (IBS-C) Market Revenue and Forecast to 2027 (US$ Mn)

8.             US Irritable Bowel Syndrome Treatment Market Analysis And Forecasts To 2027–Product

8.1       Overview

8.2       Global Irritable Bowel Syndrome Treatment Market Share by Product 2019 & 2027 (%)

8.3       Rifaximin

8.3.1        Overview

8.3.2        Rifaximin Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Eluxadoline

8.4.1        Overview

8.4.2        Eluxadoline Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Lubiprostone

8.5.1        Overview

8.5.2        Lubiprostone Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Linaclotide

8.6.1        Overview

8.6.2        Linaclotide Market Revenue and Forecast to 2027 (US$ Mn)

8.7       Others

8.7.1        Overview

8.7.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.             US Irritable Bowel Syndrome Treatment Market Analysis And Forecasts To 2027 – Distribution Channel

9.1       Overview

9.2       Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2019 & 2027 (%)

9.3       Hospitals Pharmacies

9.3.1        Overview

9.3.2        Hospitals Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Drug Stores and Retail Pharmacies

9.4.1        Overview

9.4.2        Drug Stores and Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Online Pharmacies

9.5.1        Overview

9.5.2        Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10.          US Irritable Bowel Syndrome Treatment Market –Industry Landscape

10.1    Overview

10.2    Growth Strategies In The Irritability Bowel Syndrome Treatment Market, 2017-2019

10.3    Organic Growth Strategies

10.3.1     Overview

10.3.2     Recent Organic Developments By Players In The Irritability Bowel Syndrome Treatment Market

10.4    Inorganic Growth Strategies

10.4.1     Overview

10.4.2     Recent Inorganic Developments By Players In The Irritability Bowel Syndrome Treatment Market

11.          Company Profiles

11.1    Ironwood Pharmaceuticals, Inc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2    Allergan Plc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    Sebela Pharmaceuticals, Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    Takeda Pharmaceutical Company Limited

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5    Alfasigma S.p.A.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    Astellas Pharma Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7    AstraZeneca

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8    Synthetic Biologics, Inc.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     SWOT Analysis

11.8.5     Key Developments

11.9    Bausch Health Companies Inc.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 Lannett Company Inc.

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Products and Services

11.10.4   Financial Overview

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Word Index

LIST OF TABLES

Table 1.            US: Irritable Bowel Syndrome Treatment Market Revenue Share, by Type (US$ Mn)

Table 2.            US: Irritable Bowel Syndrome Treatment Market Revenue Share, by Product (US$ Mn)

Table 3.            US: Irritable Bowel Syndrome Treatment Market Revenue Share, by Distribution Channel (US$ Mn)

Table 4.            Recent Organic Developments In The Irritability Bowel Syndrome Treatment Market

Table 5.            Recent Inorganic Developments In The Irritability Bowel Syndrome Treatment Market

Table 6.            List of Abbreviation

LIST OF FIGURES

Figure 1.          US Irritable Bowel Syndrome Treatment Market Segmentation

Figure 2.          US Irritable Bowel Syndrome Treatment Market Overview

Figure 3.          Mixed IBS (IBS–M) is Expected to Show Remarkable Growth During Forecast Period

Figure 4.          Linaclotide is Expected to Have Fastest Growth During Forecast Period

Figure 5.          US Irritable Syndrome Treatment Market, Industry Landscape

Figure 6.          US: PEST Analysis

Figure 7.          Expert Opinion

Figure 8.          Overview of US Irritable Bowel Syndrome Treatment Market

Figure 9.          Market Positioning Of Key Players In US Irritable Bowel Syndrome Treatment Market

Figure 10.       Global Irritable Bowel Syndrome Treatment Market Share by Type 2019 & 2027 (%)

Figure 11.       Mixed IBS (IBS-M) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       IBS with Diarrhea Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       IBS with Constipation (IBS-C) Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       Global Irritable Bowel Syndrome Treatment Market Share by Product 2019 & 2027 (%)

Figure 15.       Rifaximin Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Eluxadoline Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       Lubiprostone Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       Linaclotide Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2019 & 2027 (%)

Figure 21.       Hospitals Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Drug Stores and Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Growth Strategies in the Irritability Bowel Syndrome Treatment Market, 2017-2019